Presentation is loading. Please wait.

Presentation is loading. Please wait.

Efficacy of Standard Dose R-CHOP Alternating With R-HDAC Followed by Autologous Hematopoietic Cell Transplantation as Initial Therapy of Mantle Cell Lymphoma,

Published byAleesha Cooper Modified over 5 years ago

Similar presentations

Presentation on theme: "Efficacy of Standard Dose R-CHOP Alternating With R-HDAC Followed by Autologous Hematopoietic Cell Transplantation as Initial Therapy of Mantle Cell Lymphoma,"— Presentation transcript:

1 Efficacy of Standard Dose R-CHOP Alternating With R-HDAC Followed by Autologous Hematopoietic Cell Transplantation as Initial Therapy of Mantle Cell Lymphoma, a Single-Institution Experience  Yazeed Sawalha, Brian T. Hill, Lisa A. Rybicki, Danyu Sun, Robert M. Dean, Deepa Jagadeesh, Betty K. Hamilton, Aaron T. Gerds, Ronald M. Sobecks, Steven Andresen, Hien K. Liu, Navneet S. Majhail, Brad Pohlman, Matt E. Kalaycio, Brian J. Bolwell, Mitchell R. Smith  Clinical Lymphoma, Myeloma and Leukemia  Volume 18, Issue 1, Pages e95-e102 (January 2018) DOI: /j.clml Copyright © 2017 Elsevier Inc. Terms and Conditions

2 Figure 1 Progression-Free Survival for the 3 Induction Chemotherapy Regimens Abbreviations: R-CHOP = rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone; R-CHOP/R-HDAC = R-CHOP alternating with rituximab plus high-dose cytarabine; R-HCVAD/MA = cyclophosphamide, vincristine, doxorubicin, dexamethasone alternating with methotrexate, and cytarabine. Clinical Lymphoma, Myeloma and Leukemia  , e95-e102DOI: ( /j.clml ) Copyright © 2017 Elsevier Inc. Terms and Conditions

3 Figure 2 Overall Survival for the 3 Induction Chemotherapy Regimens
Abbreviations: R-CHOP = rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone; R-CHOP/R-HDAC = R-CHOP alternating with rituximab plus high-dose cytarabine; R-HCVAD/MA = cyclophosphamide, vincristine, doxorubicin, dexamethasone alternating with methotrexate, and cytarabine. Clinical Lymphoma, Myeloma and Leukemia  , e95-e102DOI: ( /j.clml ) Copyright © 2017 Elsevier Inc. Terms and Conditions

Download ppt "Efficacy of Standard Dose R-CHOP Alternating With R-HDAC Followed by Autologous Hematopoietic Cell Transplantation as Initial Therapy of Mantle Cell Lymphoma,"

Similar presentations

What We Talk About When We Talk About Fat Evan D. Rosen, Bruce M. Spiegelman Cell Volume 156, Issue 1, Pages 20-44 (January 2014) DOI: 10.1016/j.cell.2013.12.012.

What We Talk About When We Talk About Fat Evan D. Rosen, Bruce M. Spiegelman Cell Volume 156, Issue 1, Pages (January 2014) DOI: /j.cell
Cyclophosphamide plus total body irradiation compared with busulfan plus cyclophosphamide as a conditioning regimen prior to hematopoietic stem cell transplantation.

Cyclophosphamide plus total body irradiation compared with busulfan plus cyclophosphamide as a conditioning regimen prior to hematopoietic stem cell transplantation.
Single-Institution Experience in the Treatment of Primary Mediastinal B Cell Lymphoma Treated With Immunochemotherapy in the Setting of Response Assessment.

Single-Institution Experience in the Treatment of Primary Mediastinal B Cell Lymphoma Treated With Immunochemotherapy in the Setting of Response Assessment.
Risk of Atrial Fibrillation and Bleeding Diathesis Associated With Ibrutinib Treatment: A Systematic Review and Pooled Analysis of Four Randomized Controlled.

Risk of Atrial Fibrillation and Bleeding Diathesis Associated With Ibrutinib Treatment: A Systematic Review and Pooled Analysis of Four Randomized Controlled.
A-I. MD Anderson Cancer Center algorithms for Hodgkin lymphoma

A-I. MD Anderson Cancer Center algorithms for Hodgkin lymphoma
Andrzej Jakubowiak  Seminars in Hematology 

Andrzej Jakubowiak  Seminars in Hematology 
High-Dose Chemotherapy and Autologous Stem Cell Transplantation for Primary Central Nervous System Lymphoma (PCNSL) in First Complete Remission (CR1) 

High-Dose Chemotherapy and Autologous Stem Cell Transplantation for Primary Central Nervous System Lymphoma (PCNSL) in First Complete Remission (CR1) 
The Prognostic Significance of Elevated Levels of Serum Ferritin Before Chemotherapy in Patients With Non-Hodgkin Lymphoma  Kyung Ah Yoh, Ho Sup Lee,

The Prognostic Significance of Elevated Levels of Serum Ferritin Before Chemotherapy in Patients With Non-Hodgkin Lymphoma  Kyung Ah Yoh, Ho Sup Lee,
VcR-CVAD Induction Chemotherapy Followed by Maintenance Rituximab Produces Durable Remissions in Mantle Cell Lymphoma: A Wisconsin Oncology Network Study 

VcR-CVAD Induction Chemotherapy Followed by Maintenance Rituximab Produces Durable Remissions in Mantle Cell Lymphoma: A Wisconsin Oncology Network Study 
The use of high-dose cyclophosphamide, carmustine, and thiotepa plus autologous hematopoietic stem cell transplantation as consolidation therapy for high-risk.

The use of high-dose cyclophosphamide, carmustine, and thiotepa plus autologous hematopoietic stem cell transplantation as consolidation therapy for high-risk.
Heterogeneity of Second-Line Treatment for Patients With Multiple Myeloma in the Connect MM Registry (2010-2016)  Sundar Jagannath, Rafat Abonour, Brian.

Heterogeneity of Second-Line Treatment for Patients With Multiple Myeloma in the Connect MM Registry ( )  Sundar Jagannath, Rafat Abonour, Brian.
Multiple Myeloma: Diagnosis and Treatment

Multiple Myeloma: Diagnosis and Treatment
Current Therapy for Multiple Myeloma

Current Therapy for Multiple Myeloma
Secondary solid cancers after allogeneic hematopoietic cell transplantation using busulfan-cyclophosphamide conditioning by Navneet S. Majhail, Ruta Brazauskas,

Secondary solid cancers after allogeneic hematopoietic cell transplantation using busulfan-cyclophosphamide conditioning by Navneet S. Majhail, Ruta Brazauskas,
Nishitha M. Reddy, Olalekan Oluwole, John P. Greer, Brian G

Nishitha M. Reddy, Olalekan Oluwole, John P. Greer, Brian G
The Effect of Statin Use at the Time of Autologous Transplant on Response and Survival in Multiple Myeloma  Mehdi Hamadani, Erinn Hade, Don M. Benson,

The Effect of Statin Use at the Time of Autologous Transplant on Response and Survival in Multiple Myeloma  Mehdi Hamadani, Erinn Hade, Don M. Benson,
An Evaluation of Treatment Patterns and Outcomes in Elderly Patients Newly Diagnosed With Acute Myeloid Leukemia: A Retrospective Analysis of Electronic.

An Evaluation of Treatment Patterns and Outcomes in Elderly Patients Newly Diagnosed With Acute Myeloid Leukemia: A Retrospective Analysis of Electronic.
The Epidemiology and Clinical Associations of Stroke in Patients With Acute Myeloid Leukemia: A Review of 10,972 Admissions From the 2012 National Inpatient.

The Epidemiology and Clinical Associations of Stroke in Patients With Acute Myeloid Leukemia: A Review of 10,972 Admissions From the 2012 National Inpatient.
Treatment With JAK Inhibitors in Myelofibrosis Patients Nullifies the Prognostic Impact of Unfavorable Cytogenetics  Vincent T. Ma, Philip S. Boonstra,

Treatment With JAK Inhibitors in Myelofibrosis Patients Nullifies the Prognostic Impact of Unfavorable Cytogenetics  Vincent T. Ma, Philip S. Boonstra,
Limited Utility of Surveillance Imaging for Detecting Disease Relapse in Patients With Non-Hodgkin Lymphoma in First Complete Remission  Quoc Truong,

Limited Utility of Surveillance Imaging for Detecting Disease Relapse in Patients With Non-Hodgkin Lymphoma in First Complete Remission  Quoc Truong,

Similar presentations

Ads by Google